Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur heart J. 2009;30:2493–537.
PubMed
Article
Google Scholar
Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:S13–24.
Article
Google Scholar
Peacock AJ, Murphy NF, McMurray JJV, et al. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104–9.
PubMed
Article
CAS
Google Scholar
Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023–30.
PubMed
Article
Google Scholar
Machado R, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S32–42.
PubMed
Article
CAS
Google Scholar
Sztrymf, Coulet F, Girerd B, et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR mutation. Am J Respir Crit Care Med. 2008;177:1377–83.
PubMed
Article
CAS
Google Scholar
Cabane J, Frances C, Launay D, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum. 2005;52:3792–800.
PubMed
Article
Google Scholar
Hachulla E, Gressin V, Guillevin L, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62:1088–93.
Article
Google Scholar
Opravil M, Sereni D. Natural history of HIV-associated pulmonary arterial hypertension:trends in the HAART era. Aids. 2008;suppl 3: S35–S40.
Google Scholar
Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med. 2008;177:108–13.
PubMed
Article
Google Scholar
Le Pavec J, Souza R, Herve P, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med. 2008;178(6):637–43.
PubMed
Article
Google Scholar
Duffels MGJ, Engelfriet PM, Berger RMF, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120(2):198–204.
PubMed
Article
CAS
Google Scholar
Galie N, Manes A, Palazzini M, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger’s syndrome. Drugs. 2008;68:1049–66.
PubMed
Article
CAS
Google Scholar
Lapa M, Dias B, Jardim C, et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation. 2009;119(11):1518–23.
PubMed
Article
Google Scholar
van Loon RL, Roofthooft MT, Osch-Gevers M, et al. Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis. J Pediatr. 2009;155:176–82.
PubMed
Article
Google Scholar
Humbert M, Maître S, Capron F, et al. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am J Respir Crit Care Med. 1998;157:1681–5.
PubMed
CAS
Google Scholar
Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology. 2004;43:461–6.
PubMed
Article
CAS
Google Scholar
Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advance lung disease. Am J Respir Crit Care Med. 2003;167:735–40.
PubMed
Article
Google Scholar
Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum. 2005;52:3792–800.
PubMed
Article
Google Scholar
Clayton LM, Jobsis MM, Crow JW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214–9.
PubMed
Article
Google Scholar
Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034–41.
PubMed
Article
Google Scholar
Hummel M, Hetzer R, Ewert R. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation. 2002;106:319–24.
PubMed
Article
Google Scholar
Shah SJ, Thenappan T, Rich S, et al. Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension. Circ Heart Fail. 2009;2:278–86.
PubMed
Article
Google Scholar
Okajima Y, Ohno Y, Washko GR, et al. Assessment of pulmonary hypertension: What CT and MRI can provide. Acad Radiol. 2011;18:437–53.
PubMed
Article
Google Scholar
Benza R, Biederman R, Murali S, et al. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2008;52(21):1683–92.
PubMed
Article
Google Scholar
Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48:2546–52.
PubMed
Article
Google Scholar
Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111:3105–11.
PubMed
Article
CAS
Google Scholar
Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest. 2006;129:1313–21.
PubMed
Article
CAS
Google Scholar
Johnson SR, Mehta S, Granton JT. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur Respir J. 2006;28(5):999–1004.
PubMed
Article
CAS
Google Scholar
Galiè N, Begh M, Gat M, et al. Bosentan randomized trial of endothelin antagonist therapy-5 (BREATHE-5) Investigator. Bosentan therapy in patients with Eisenmenger Syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114:48–54.
PubMed
Article
Google Scholar
Barbaro G, Luccini A, Pellicelli AM, et al. Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension. Heart. 2006;92(8):1164–6.
PubMed
Article
CAS
Google Scholar
Cartin-Ceba R, Swanson K, Iyer V, et al. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest. 2011;139(1):109–14.
PubMed
Article
CAS
Google Scholar
Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334:296–302.
PubMed
Article
CAS
Google Scholar
Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension. A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800–4.
PubMed
Google Scholar
Olschewski H, Simonneau G, Galie N, for the AIR Study Group, et al. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med. 2002;347:322–9.
PubMed
Article
CAS
Google Scholar
Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet. 2001;358(9288):1119–23.
PubMed
Article
CAS
Google Scholar
Humbert M, Barst RJ, Robbins IM, et al. BREATHE-2 combination of bosentan with epoprostenol in pulmonary arterial hypertension. Eur Respir J. 2004;24(3):353–9.
PubMed
Article
CAS
Google Scholar
Sitbon O, McLaughlin VV, Badesch DB, et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax. 2005;60:1025–30.
PubMed
Article
CAS
Google Scholar
Galiè N, Rubin L, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY Study). Lancet. 2008;371:2093–100.
PubMed
Article
Google Scholar
Galie N, Olschewski H, Oudiz RJ, et al. Ambrisentan for the treatment of pulmonary arterial hypertension. Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation. 2008;117:3010–9.
PubMed
Article
CAS
Google Scholar
Galie N, Ghofrani HA, Torbicki A, et al. The Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. New Engl J Med. 2005;353:2148–57.
PubMed
Article
CAS
Google Scholar
Galie N, Brundage B, Ghofrani A, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119:2894–903.
PubMed
Article
CAS
Google Scholar
Hoeper MM, Markevych I, Spiekerkoetter E, et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J. 2005;26(5):858–63.
PubMed
Article
CAS
Google Scholar
McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114:1417–31.
PubMed
Article
Google Scholar
Quark R, Nawrot T, Meyns B, et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53:1211–8.
Article
Google Scholar
Henkens IR, van Wolveren SA, Gan CT, et al. Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol. 2009;103:1451–6.
PubMed
Article
Google Scholar
Simonneau G, Rubin L, Galie N, for the Pulmonary Arterial Hypertension combination Study of Epoprostenol and Sildenafil (PACES) Study Group, et al. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension. Ann Intern Med. 2008;149:521–30.
PubMed
Google Scholar
McLaughlin VV, Oudiz RJ, Frost A, et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006;174:1257–63. combi.
PubMed
Article
CAS
Google Scholar
Kurzyna M, Dabrowski M, Bielecki D, et al. Atrial eptostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007;131:977–83.
PubMed
Article
Google Scholar
Chen H, Shiboski SC, Golden JA, et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;180:385–7.
Article
Google Scholar